From: One-year effects of two intensive inpatient treatments for severely obese children and adolescents
 | Short-stay | Long-stay | Crude | Adjusted |
---|---|---|---|---|
Mean (SD) | Mean (SD) | Beta (95Â % CI) | Beta (95Â % CI) | |
Primary outcome measure | ||||
SDS-BMI | ||||
 Baseline | 3.7 (0.4) | 3.7 (0.4) |  |  |
 6-months | 3.4 (0.6) | 3.1 (0.7) | 0.25 (−0.03; 0.52) | 0.23 (−0.07; 0.53) |
 12-months | 3.4 (0.7) | 2.9 (0.8) | 0.34 (−0.09; 0.77) | 0.31 (−0.14; 0.76) |
 Overall effecta |  |  | 0.25 (−0.15; 0.64) | 0.26 (−0.15; 0.67) |
Secondary outcomes | ||||
SDS-waist circumference | ||||
 Baseline | 3.5 (0.4) | 3.3 (0.3) |  |  |
 6-months | 3.0 (0.7) | 2.6 (0.6) | 0.10 (−0.35; 0.55) | 0.05 (−0.39; 0.48) |
 12-months | 3.0 (1.0) | 2.4 (0.9) | 0.12 (−0.48; 0.72) | 0.01 (−0.57; 0.60) |
 Overall effecta |  |  | 0.40 (−0.03; 0.83) | 0.40 (−0.06; 0.86) |
Systolic blood pressure (mmHg) | ||||
 Baseline | 124.3 (15.0) | 125.1 (14.0) |  |  |
 6-months | 122.0 (18.7) | 120.2 (11.9) | 3.34 (−5.35; 12.03) | 4.31 (−3.56; 12.19) |
 12-months | 122.1 (12.3) | 123.3 (14.4) | −1.46 (−9.12; 6.20) | 0.45 (−6.74; 7.64) |
 Overall effecta |  |  | 0.52 (−9.22; 10.25) | 2.04 (−8.27; 12.36) |
Diastolic blood pressure (mmHg) | ||||
 Baseline | 77.7 (11.0) | 80.9 (9.2) |  |  |
 6-months | 64.4 (8.0) | 68.2 (10.0) | −1.61 (−8.46; 5.24) | −2.91 (−9.17; 3.35) |
 12-months | 69.4 (8.3) | 66.5 (11.7) | 5.28 (−0.21; 10.76) | 3.86 (−2.23; 9.94) |
 Overall effecta |  |  | −0.73 (−7.66, 4.06) | −1.80 (−7.66, 4.06) |
Fasting insulin (μU/L) | ||||
 Baseline | 15.3 (7.7) | 16.2 (13.2) |  |  |
 6-months | 12.4 (12.6) | 11.8 (11.0) | 0.78 (−4.44; 6.00) | 0.73 (−4.54; 6.00) |
 12-months | 11.1 (5.8) | 14.4 (13.8) | −0.82 (−4.84; 3.20) | −1.15 (−5.06; 2.76) |
 Overall effecta |  |  | −0.58 (−7.69; 6.53) | 0.14 (−6.93; 7.22) |
2 h-insulin (μU/L) | ||||
 Baseline | 75.4 (50.2) | 53.3 (34.6) |  |  |
 6-months | 64.5 (68.2) | 38.6 (20.2) | 13.21 (−21.43; 47.84) | 14.30 (−18.69; 47.29) |
 12-months | 65.1 (41.3) | 62.7 (33.8) | 2.81 (−14.94; 20.56) | 3.47 (−16.01; 22.96) |
 Overall effecta |  |  | 21.31 (−7.19; 49.81) | 22.60 (−5.09; 50.30) |
Fasting glucose (mmol/L) | ||||
 Baseline | 4.6 (0.2) | 4.8 (0.4) |  |  |
 6-months | 4.8 (0.3) | 4.7 (0.3) | 0.14 (−0.05; 0.34) | 0.14 (−0.05; 0.34) |
 12-months | 4.7 (0.3) | 5.0 (0.2) | −0.16 (−0.36; 0.04) | −0.17 (−0.36; 0.02) |
 Overall effecta |  |  | −0.14 (−0.31; 0.03) | −0.10 (−0.25; 0.06) |
2Â h-glucose (mmol/L) | ||||
 Baseline | 6.3 (1.1) | 5.7 (0.9) |  |  |
 6-months | 5.7 (1.5) | 4.9 (0.9) | 0.43 (−0.47; 1.33) | 0.48 (−0.39; 1.34) |
 12-months | 5.6 (0.9) | 6.0 (1.1) | −0.40 (−1.06; 0.27) | −0.43 (−1.14; 0.29) |
 Overall effecta |  |  | 0.42 (−0.26; 1.10) | 0.49 (−0.25; 1.23) |
HDL-cholesterol (mmol/L) | ||||
 Baseline | 1.1 (0.3) | 1.0 (0.2) |  |  |
 6-months | 1.1 (0.4) | 1.1 (0.2) | −0.08 (−0.18; 0.13) | −0.08 (−0.19; 0.03) |
 12-months | 1.2 (0.5) | 1.2 (0.4) | −0.08 (−0.27; 0.11) | −0.07 (−0.28; 0.15) |
 Overall effecta |  |  | 0.05 (−0.17; 0.28) | 0.08 (−0.13; 0.29) |
Triglycerides (mmol/L) | ||||
 Baseline | 1.0 (0.5) | 1.2 (0.7) |  |  |
 6-months | 1.1 (0.7) | 1.1 (0.7) | 0.13 (−0.30, 0.56) | 0.06 (−0.31, 0.44) |
 12-months | 1.4 (0.9) | 1.4 (0.9) | −0.06 (−0.51, 0.63) | −0.04 (−0.56, 0.48) |
 Overall effecta |  |  | −0.10 (−0.56, 0.36) | −0.10 (−0.52, 0.33) |
HOMA-IR | ||||
 Baseline | 3.1 (1.5) | 3.5 (3.0) |  |  |
 6-months | 2.7 (2.7) | 2.5 (2.4) | 0.40 (−0.77; 1.58) | 0.37 (−0.80; 1.54) |
 12-months | 2.3 (1.2) | 3.3 (3.3) | −0.17 (−1.05, 0.72) | −0.27 (−1.12, 0.59) |
 Overall effecta |  |  | −0.30 (−1.87; 1.28) | −0.12 (−1.68; 1.44) |